Literature DB >> 3079685

Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody.

C Cunningham-Rundles, S Wong, J Björkander, L A Hanson.   

Abstract

In this report we describe the use of an IgA-depleted preparation of intravenous gamma-globulin in a patient with hypogammaglobulinemia and an anti-IgA antibody. An IgA containing intravenous gamma-globulin had previously produced anaphylactoid reactions, immune complex formation, and complement activation. The patient has had no reactions to the IgA-depleted preparation after 18 months of treatment; immune complex formation and complement activation have not been demonstrated, and the titer of antibody to IgA has diminished.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079685     DOI: 10.1016/0090-1229(86)90133-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy.

Authors:  R de Albuquerque Campos; M N Sato; A J da Silva Duarte
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

2.  Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion.

Authors:  Rima Rachid; Mariana Castells; Charlotte Cunningham-Rundles; Francisco A Bonilla
Journal:  J Allergy Clin Immunol       Date:  2011-03-11       Impact factor: 10.793

3.  Anti-IgA antibodies in IgA-deficient children.

Authors:  F H Sennhauser; C S Hosking; C L Jones; R A MacDonald; N Mermelstein; D M Roberton
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

4.  Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies.

Authors:  C Cunningham-Rundles; Z Zhou; S Mankarious; S Courter
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

Review 5.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

6.  Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy.

Authors:  U Sundin; S Nava; L Hammarström
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

7.  Anaphylaxis to IGIV in immunoglobulin-naïve common variable immunodeficiency patient in the absence of IgG anti-IgA antibodies: successful administration of low IgA-containing immunoglobulin.

Authors:  Asal Gharib; Caroline Caperton; Sudhir Gupta
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-17       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.